Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 8,560.00
+190.00 (2.27%)
Jun 12, 2026, 3:30 PM KST
Komipharm International Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6,398 | -7,209 | 13,113 | -3,979 | -6,514 | -4,459 |
Depreciation & Amortization | 2,703 | 2,838 | 3,100 | 3,529 | 3,826 | 3,582 |
Loss (Gain) From Sale of Assets | -0.9 | -1.2 | -9,073 | -64.42 | 2.43 | -0.81 |
Asset Writedown & Restructuring Costs | 1,326 | 1,326 | 1,395 | 247.4 | 186.19 | - |
Loss (Gain) From Sale of Investments | 342.41 | 342.41 | 544.62 | -211.87 | 2,914 | 309.41 |
Loss (Gain) on Equity Investments | 38.38 | 38.38 | 27.7 | -36.84 | - | - |
Stock-Based Compensation | 6.7 | - | - | 26.89 | 115.45 | 115.45 |
Provision & Write-off of Bad Debts | 607.28 | 510.6 | -334.6 | 478.09 | 415.78 | 274.4 |
Other Operating Activities | 6,691 | 7,510 | 1,324 | -2,727 | -271.46 | -733.63 |
Change in Accounts Receivable | -3,237 | -3,040 | -2,720 | -1,579 | -1,418 | 806.47 |
Change in Inventory | -1,538 | -918.73 | 218.95 | 1,334 | -2,114 | -361.37 |
Change in Accounts Payable | -538.98 | -1,473 | 1,695 | 1,939 | 840.49 | -1,136 |
Change in Other Net Operating Assets | -1,226 | -545.41 | -444.25 | -1,606 | 209.58 | 346.82 |
Operating Cash Flow | -1,224 | -621.8 | 8,847 | -2,800 | -1,808 | -1,256 |
Capital Expenditures | -3,389 | -3,087 | -1,045 | -636.78 | -847.71 | -813.43 |
Sale of Property, Plant & Equipment | 1 | 1.3 | 15,484 | 87.21 | 2.79 | 1 |
Sale (Purchase) of Intangibles | -1,813 | -1,384 | -2,933 | -492.13 | -217.56 | -370.29 |
Investment in Securities | -962.83 | 9,995 | -8,904 | -1,013 | 20.41 | 1,911 |
Other Investing Activities | -1.03 | -99.03 | -239.27 | 1,103 | 18.05 | -379 |
Investing Cash Flow | -5,598 | 5,844 | 1,979 | -3,502 | -1,376 | -744.84 |
Short-Term Debt Issued | - | - | 4,000 | 3,000 | 3,000 | 8,500 |
Long-Term Debt Issued | - | 15,461 | 5,400 | 17,000 | 2,000 | 10,000 |
Total Debt Issued | 15,461 | 15,461 | 9,400 | 20,000 | 5,000 | 18,500 |
Short-Term Debt Repaid | - | - | -6,600 | -3,400 | -1,000 | -5,590 |
Long-Term Debt Repaid | - | -1,096 | -5,990 | -5,968 | -966.26 | -13,931 |
Total Debt Repaid | -1,098 | -1,096 | -12,590 | -9,368 | -1,966 | -19,521 |
Net Debt Issued (Repaid) | 14,363 | 14,365 | -3,190 | 10,632 | 3,034 | -1,021 |
Repurchase of Common Stock | -4,012 | -2,879 | -3,678 | -62.89 | -999.51 | - |
Other Financing Activities | -1,282 | -1,282 | -6,362 | -37.87 | -0 | -1.11 |
Financing Cash Flow | 9,069 | 10,204 | -13,231 | 10,531 | 2,034 | -1,022 |
Foreign Exchange Rate Adjustments | 323.57 | 13.88 | 33.34 | -214.45 | -37.89 | -34.25 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -0 | - | - |
Net Cash Flow | 2,571 | 15,440 | -2,372 | 4,015 | -1,187 | -3,057 |
Free Cash Flow | -4,612 | -3,709 | 7,802 | -3,437 | -2,656 | -2,069 |
Free Cash Flow Margin | -9.23% | -7.07% | 13.27% | -8.06% | -6.67% | -5.77% |
Free Cash Flow Per Share | -59.98 | -52.43 | 111.85 | -48.99 | -37.78 | -29.45 |
Cash Interest Paid | 1,130 | 1,158 | 1,398 | 1,336 | 779.15 | 537.88 |
Cash Income Tax Paid | 23.14 | 19.65 | 21.79 | 61.32 | -0.93 | 134.37 |
Levered Free Cash Flow | 767.03 | 2,563 | -1,527 | -2,004 | -3,218 | -2,886 |
Unlevered Free Cash Flow | 2,202 | 4,188 | 476.53 | -408.89 | -1,833 | -1,850 |
Change in Working Capital | -6,540 | -5,978 | -1,250 | -62.22 | -2,482 | -343.85 |